Who is the CEO of Vijaypd Ceutical Ltd?
- Answer Field
-
The promoters include Samit Madhukar Shah, Bhavin Dhirendra Shah, Rahul Dhirendra Shah, Narendra Nagindas Shah, Dina Madhukar Shah, and Hemanti Jitendra Shah.
Vijaypd Ceutical Ltd, incorporated in 1971, has built itself as a distributor and supplier at the intersection of pharmaceuticals and FMCG. The company acts as dealer, stockist, and agent across categories—bridging manufacturers with clinics, pharmacies, and wellness outlets. Its distribution network covers over 20 locations, serving more than 2,100 pharmacies, clinics, and nursing homes.
The product base is vast. From injections, capsules, and oral formulations to vitamins, hormones, and diagnostic kits on one side, and ayurvedic goods, soaps, cosmetics, and food items on the other. With over 170 manufacturing partners and access to 19,000+ SKUs, the company has positioned itself as a comprehensive player in healthcare and wellness supply. Investors viewing this IPO will note both the long operating history and the diversified portfolio across pharmaceutical essentials and consumer products. For further details, you can check the official Vijaypd Ceutical IPO page.
Particulars | Details |
IPO Date | September 29, 2025 – October 1, 2025 |
Issue Size | ₹19.25 Cr (55,00,000 shares) |
Fresh Issue | Entirely Fresh Issue of 55,00,000 shares |
Issue Price | ₹35 per share |
Face Value | ₹10 per share |
Lot Size | 4,000 shares |
Listing At | NSE SME |
Lead Manager | Smart Horizon Capital Advisors Pvt. Ltd. |
Registrar | Kfin Technologies Ltd. |
Construction of an API/Intermediates and Chemicals manufacturing plant with machinery purchase at MIDC, Shrirampur, Ahmednagar (₹10.83 Cr).
Repayment or prepayment of borrowings (₹5.10 Cr).
General corporate purposes (₹0.74 Cr).
Event | Date |
IPO Open Date | Mon, Sep 29, 2025 |
IPO Close Date | Wed, Oct 1, 2025 |
Allotment Finalization | Fri, Oct 3, 2025 |
Refund Initiation | Mon, Oct 6, 2025 |
Credit of Shares | Mon, Oct 6, 2025 |
Listing Date | Tue, Oct 7, 2025 |
Cut-off for UPI Confirmation | 5 PM, Oct 1, 2025 |
The schedule is tentative and subject to change as per exchange approvals.
Price Band for the IPO: Fixed at ₹35 per share.
Minimum Lot Size and Application Details:
Retail Investors: Minimum 2 lots (8,000 shares), ₹2,80,000.
HNI: Minimum 3 lots (12,000 shares), ₹4,20,000.
Applications must be placed in multiples of 4,000 shares.
Investors can apply online through their broker or trading platform. Once bidding is placed, UPI confirmation is required to complete the process.
The IPO comprises a total of 55,00,000 shares. The net offer is distributed across retail and HNI investors, with a small portion for the market maker.
Investor Category | Shares Offered | % of Offer |
Market Maker | 2,84,000 | 5.16% |
NII (HNI) | 26,08,000 | 47.42% |
Retail | 26,08,000 | 47.42% |
Total | 55,00,000 | 100% |
Total Income FY25: ₹107.59 Cr
Profit After Tax (PAT) FY25: ₹4.80 Cr
EBITDA FY25: ₹8.59 Cr
Net Worth: ₹32.17 Cr
Borrowings: ₹21.77 Cr
Revenue rose 98% YoY (FY25 vs FY24).
PAT jumped 191% in the same period.
Growth has been supported by a diversified product basket, steady demand across pharma and FMCG, and expansion of its distribution footprint.
Strong presence with certifications like FDA, FSSAI, and BMC adds credibility in regulated markets.
Heavy reliance on external manufacturing partners may limit control over supply.
High working capital needs in distribution may affect liquidity.
Debt levels remain notable despite recent repayments.
Regulatory scrutiny in pharmaceuticals and FMCG could create compliance risks.
Expanding into API/intermediates manufacturing could diversify revenues.
Large distribution footprint and client network provide steady cash flows.
Demand for wellness, ayurvedic, and FMCG products is growing alongside pharma.
Strong YoY growth trajectory in FY25 shows potential for scale-up.
KPI | Values |
ROE | 28.91% |
ROCE | 17.30% |
Debt/Equity | 0.68 |
RoNW | 14.91% |
PAT Margin | 4.49% |
EBITDA Margin | 8.04% |
Particulars | Details |
Registrar | Kfin Technologies Ltd. |
Registrar Email | vcl.ipo@kfintech.com |
Registrar Phone | 040-67162222, 040-79611000 |
Registrar Website | |
Lead Manager | Smart Horizon Capital Advisors Pvt. Ltd. |
Vijaypd Ceutical Ltd A/1, 1st Floor, Devraj Premises, CHSL, Goregaon West, Mumbai, Maharashtra – 400062
Phone: +91 9820917040
Email: investors@vijaypdceutical.com
Website: www.vijaypdceutical.com
Vijaypd Ceutical Ltd steps into the SME market with a mix of legacy and growth ambitions. Having operated since 1971, it has built deep distribution networks across pharma, FMCG, and wellness products.
The IPO is set to fund expansion into API and intermediates manufacturing while also reducing debt. For a company long rooted in distribution, this diversification adds another layer of strategy, combining scale in supply with forward-looking investment in production.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Vijaypd Ceutical IPO allotment status.
Share this article:
No result found
The promoters include Samit Madhukar Shah, Bhavin Dhirendra Shah, Rahul Dhirendra Shah, Narendra Nagindas Shah, Dina Madhukar Shah, and Hemanti Jitendra Shah.
The IPO opens on September 29, 2025, and closes on October 1, 2025.
The company distributes pharmaceuticals, FMCG, and wellness products. Sustainability depends on demand for essential healthcare goods, breadth of its distribution network, and the planned expansion into API manufacturing.
₹19.25 crore (entirely fresh issue of 55,00,000 shares).
Pre-apply lets investors submit applications before the IPO opens, subject to UPI confirmation.
1 lot = 4,000 shares. Minimum for retail is 2 lots (8,000 shares), requiring ₹2,80,000.
Tentative allotment date is October 3, 2025.
Kfin Technologies Ltd.
No governance issues have been highlighted in the RHP.
Login to broker platform, select IPO, enter details, provide UPI ID, and confirm the application.
Yes, a Demat account is mandatory.
Allotment status can be checked on the registrar’s website after allotment finalization.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading